HIV PrEP With Injectable Cabotegravir Superior To Oral TDF-FTC Among Women In Phase III Trial

Infectious Disease Advisor (5/5, Nye) reports, “Among women, HIV pre-exposure prophylaxis (PrEP) with injectable cabotegravir was superior to oral tenofovir diphosphate plus emtricitabine (TDF-FTC), according to results of a phase 3, randomized, double-bl...